Drug intelligence / Profile preview

Experimental Peritoneal Dialysis Solution

Development stage: Preclinical
Lead developer: Vanttive
Administration: Peritoneal

Overview

Experimental Peritoneal Dialysis Solution is a novel solution under investigation for the management of end-stage renal disease (ESRD) in patients undergoing peritoneal dialysis. Developed by Vantive Health LLC, this solution is being evaluated for its efficacy and safety, as well as its potential to reduce inflow pain compared to existing peritoneal dialysis solutions.

Beyond the preview

Go deeper on Experimental Peritoneal Dialysis Solution.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Experimental Peritoneal Dialysis Solution.

Explore the full profile